Associate Professor of Medicine, Beth Israel Deaconess Medical Center
Cardiology
Dr. Donald E. Cutlip, MD
|
|
Give Review
Donald E. Cutlip is an expert in the field of Cardiology. He graduated from University of South Florida College of Medicine. University of South Florida College of Medicine has a rank of 79 in research and a 85 in primary care He has 2 awards "Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Dr. Donald E. Cutlip is a published doctor. He published 90 publications, including: 'Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.' Donald Cutlip accepts Medicare.
Publications
- Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
- Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease: Consensus Definitions From Peripheral Academic Research Consortium (PARC).
- Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy.
- Benefits and Risks of Extended Duration Dual Antiplatelet Therapy after PCI in Patients With and Without Acute Myocardial Infarction.
- Antiplatelet therapy duration following bare metal or drug-eluting Coronary stents: the dual antiplatelet therapy randomized clinical trial.
- Supervised Exercise, Stent Revascularization, or Medical Therapy for Claudication Due to Aortoiliac Peripheral Artery Disease: The CLEVER Study.
- A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of Coronary bifurcation lesions.
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents.
- APPOSITION V: STENTYS Coronary stent system clinical trial in subjects with ST-segment elevation myocardial infarction-Rationale and design.
- Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor...
- Use of Renin-Angiotensin Inhibitors in People with Renal Artery Stenosis.
- Usefulness of Postmarket Studies to Evaluate Long-Term Safety of Coronary Eluting Stents (from the ENDEAVOR and PROTECT Programs).
- Roll-in Experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) Study.
- Everolimus-eluting stents in patients undergoing percutaneous Coronary intervention: Final 3-year results of the Clinical Evaluation of the XIENCE V Everolimus Eluting...
- Long-term efficacy and safety of zotarolimus-eluting stent in patients with diabetes mellitus: Pooled 5-year results from the ENDEAVOR III and IV trials.
- Five-Year Results of a Randomized Comparison of XIENCE V Everolimus-Eluting and TAXUS Paclitaxel-Eluting Stents: Final Results From the SPIRIT III Trial.
- Stenting and medical therapy for atherosclerotic renal-Artery stenosis.
- Frequency of the Use of Low- Versus High-Dose Aspirin in Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (from the Dual Antiplatelet Therapy Study).
- Meta-Analysis of Everolimus-Eluting Versus Paclitaxel-Eluting Stents in Coronary Artery Disease: Final 3-Year Results of the SPIRIT Clinical Trials Program (Clinical E...
- Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive Disease: A meta-analysis and critical examination of current methodologies.
- Correlation of Patient-reported Symptom Outcomes and Treadmill Test Outcomes after Treatment for Aortoiliac Claudication.
- Nonemergency PCI at hospitals with or without on-site cardiac surgery.
- The "Final" 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting Stent.
- Impact of time-to-treatment on myocardial perfusion after primary percutaneous Coronary intervention with Gp IIb-IIIa inhibitors.
- Red cell distribution width is a predictor of mortality in patients undergoing percutaneous Coronary intervention.
- Updated standardized endpoint definitions for transcatheter Aortic valve implantation: the Valve Academic Research Consortium-2 consensus document.
- Disappearing stents-DREAMS of a sorcerer's apprentice?
- Platelet-Mediated Thrombosis and Drug-Eluting Stents.
- Frequency and impact of bleeding in elective Coronary stent clinical trials-Utility of three commonly used definitions.
- Clinical pearls regarding Prinzmetal's Angina complicated by cardiac arrest - management during therapeutic hypothermia.
- Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous Coronary intervention between MASSachusetts hospitals with cardiac surgery on-s...
- Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention.
- Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium.
- A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in Coronary arte...
- Five-Year Outcomes of Sirolimus-Eluting and Paclitaxel-Eluting Stents in Routine Clinical Practice: Are They Equally Good (or Bad)?
- The academic research consortium governance charter.
- Autopsy validation study of the academic research consortium stent thrombosis definition.
- Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial).
- Carotid artery stenting vs Carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials.
- Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium.
- FAME and Coronary stent investigations: is there a kink in the wire?
- Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of ...
- In-hospital and nine-month outcomes among patients with Coronary lesions involving a side branch and treated with bare metal stents.
- Long-term clinical outcomes with zotarolimus-eluting versus bare-metal Coronary stents.
- Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 ve...
- Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials).
- Effect of Coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents.
- The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase.
- SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with Coronary artery disease.
- Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
- Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.
- Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.
- Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting ...
- Drug-eluting or bare-metal stents for ST elevation Myocardial infarction can observational data balance the risk benefit equation?
- Precordial Steering Wheel: A Fortunate Accident.
- Reduction in sex-based mortality difference with implementation of new cardiology guidelines.
- Clinical, procedural, and pharmacologic correlates of Acute and subAcute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
- Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients.
- Gender-specific outcomes after sirolimus-eluting stent implantation.
- Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic p...
- Long-term clinical outcomes with sirolimus-eluting Coronary stents: five-year results of the RAVEL trial.
- Offsetting impact of thrombosis and restenosis on the occurrence of death and Myocardial infarction after paclitaxel-eluting and bare metal stent implantation.
- A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.
- Safety and efficacy of sirolimus- and paclitaxel-eluting Coronary stents.
- Stent thrombosis in randomized clinical trials of drug-eluting stents.
- Hospital delays in reperfusion for ST-elevation Myocardial infarction: implications when selecting a reperfusion strategy.
- Effect of diabetes mellitus on five-year clinical outcomes after single-vessel Coronary stenting (a pooled analysis of Coronary stent clinical trials).
- Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.
- Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous Coronary interventions: results...
- Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials.
- Obesity and clinical restenosis after Coronary stent placement.
- Does creatinine kinase-MB elevation after percutaneous Coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous Coronary ...
- Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
- Relationship of late loss in lumen diameter to Coronary restenosis in sirolimus-eluting stents.
- Effect of gender on in-hospital and one-year outcomes after contemporary Coronary artery stenting.
- Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.
- Beyond restenosis: five-year clinical outcomes from second-generation Coronary stent trials.
- Effects of stent length and lesion length on Coronary restenosis.
- Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues.
- Stent thrombosis after successful sirolimus-eluting stent implantation.
- Risk assessment for percutaneous Coronary intervention: our version of the weather report?
- Incidence and predictors of late total occlusion following Coronary stenting.
- Effect of tirofiban before primary angioplasty on initial coronary flow and early ST-segment resolution in patients with Acute myocardial infarction.
- Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small Coronary arteries: results of the Dilatation vs Abl...
- Clinical restenosis after Coronary stenting: perspectives from multicenter clinical trials.
- Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial.
- Rheolytic thrombectomy and platelet glycoprotein IIb/IIIa blockade for stent thrombosis.
- Cost-Effectiveness of Supervised Exercise, Stenting, and Optimal Medical Care for Claudication: Results From the Claudication: Exercise Versus Endoluminal Revasculariz...
- Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study.
Schools
University Of Florida College Of Medicine
Beth Israel Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Beth Israel Deaconess Medical Center -
University of Connecticut -
University of South Florida College of Medicine
Hospital
-
Beth Israel Deaconess Medical Center
Drug Facts
| NPI NUMBER | 1396777827 | |
| NPPES Provider LastName | CUTLIP | |
| NPPES Provider FirstName | DONALD | |
| NPPES Provider ZIPCode | 02215 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 374.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396777827 |
| Last Name Of The Provider | CUTLIP |
| First Name Of The Provider | DONALD |
| View All |
Similar Doctors
|
|
Dr. Calum A. MacRae, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan O. Stitziel, MD |
|
|
Dr. Amil M. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danita Y. Sanborn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew O. Maree, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Bryan P. Yan, MB BS
This Doctor is OpenDoctor Recommended.
|
|
|
Owen C. Raffel, MB CHB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. J Stephen Bohan, MD |
|
|
Dr. Zoltan P. Arany, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Devraj Sukul, MD |
|
|
Dr. Eric Ackah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jae B. Kim, MD |
|
|
Dr. Peter Ganz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie A. Moore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laurence M. Epstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert O. Blaustein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Denofrio, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. J G. Corrodi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark N. Nallaratnam, MD
This Doctor is OpenDoctor Recommended.
|